The Joint British Diabetes Societies guideline for the management of diabetic ketoacidosis” recommends continuation of long-acting insulin analog during the initial management of DKA because it provides background insulin when the intravenous insulin is discontinued” (6, 24). The gene discussed is INS; the disease is diabetes mellitus.